1.1.2. Articolo in Rivista

1.1.2. Articolo in Rivista - Letter: [926] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 926

Disease progression in myeloproliferative neoplasms: Comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

2020-01-01 Geyer, J. T.; Margolskee, E.; Krichevsky, S. A.; Cattaneo, D.; Boiocchi, L.; Ronchi, P.; Lunghi, F.; Scandura, J. M.; Ponzoni, M.; Hasserjian, R. P.; Gianelli, U.; Iurlo, A.; Orazi, A.

Anti-cytokine treatment for Takayasu arteritis: State of the art

2014-01-01 Tombetti, E.; Di Chio, M. C.; Sartorelli, S.; Bozzolo, E.; Sabbadini, M. G.; Manfredi, A.; Baldissera, E.

The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy

2022-01-01 Martini, A.; Raggi, D.; Marandino, L.; Montorsi, F.; Ross, J. S.; Gibb, E. A.; Necchi, A.

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer

2020-01-01 D'Andrea, D.; Foerster, B.; Matin, S. F.; Ku, J. H.; Muilwijk, T.; Monteiro, L. L.; Liao, R.; Petros, F. G.; Spiess, P. E.; Bivalacqua, T. J.; Hendricksen, K.; Van Rhijn, B. W. G.; Shabsigh, A.; Briganti, A.; Joniau, S.; Kassouf, W.; Pierorazio, P. M.; Margulis, V.; Necchi, A.; Shariat, S. F.

ACh receptor in ocular MG

1994-01-01 Horton, R. M.; Conti-Tronconi, B. M.; Manfredi, A.

Do putative endogenous digitalis-like factors have a physiological role?

1994-01-01 Hansen, O.; Doris, P. A.; Hamlyn, J. M.; Laredo, J.; Lu, Z. -R.; Hamilton, B.; Lighthall, G.; Manunta, P.

Cytoreductive Nephrectomy in 2021: Obsolete but Necessary

2022-01-01 Capitanio, U.; Necchi, A.; Montorsi, F.; Larcher, A.

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply

2026-01-01 Lanzillotta, M.; Vikse, J.; Goni, E.; Hoffmann-Vold, A. M.; Della-Torre, E.

Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease

2025-01-01 Minici, C.; Mahajne, J.; Orfanelli, U.; Lanzillotta, M.; Della-Torre, E.

Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison

2026-01-01 Marino, V.; Moiola, L.; Zanetta, C.; Rubin, M.; Rossi, L.; Margoni, M.; Nozzolillo, A.; Gattuso, I.; Viti, V.; Petza, E.; Rocca, M. A.; Guerrieri, S.; Filippi, M.

Silent Risk, Real-World Insight From an Italian Center: Rethinking Intracranial Aneurysm Screening in ADPKD

2025-01-01 De Rosa, L. I.; Catania, M.; Kristiana, K.; Paolisi, M.; Bianca, P.; Farinone, S.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.

SunRISe-4 perioperative safety and TURBT stratification – Authors' reply

2025-01-01 Necchi, A.; Stitou, H.; Bhanvadia, S.; Psutka, S. P.

Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review

2026-01-01 Stabile, A.; Brancaccio, M.; Scilipoti, P.; Barletta, F. M.; Scuderi, S.; Quarta, L.; Cosenza, A.; Zaurito, P.; Porzi, M. E.; Imperiale, G.; Brembilla, G.; Cobelli, F. D.; Pini, C.; Chiti, A.; Colecchia, M.; Montorsi, F.; Gandaglia, G.; Briganti, A.

Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery

2026-01-01 Scilipoti, P.; Rosiello, G.; Salonia, A.; Briganti, A.; Necchi, A.; Moschini, M.; Montorsi, F.

Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis. Reply

2025-01-01 Mapelli, Chiara; Nassisi, Marco; Beretta, Gisella B; Miserocchi, Elisabetta; Filocamo, Giovanni; Minoia, Francesca

Re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance Imaging–led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. Eur Urol 2025;88:167–75

2026-01-01 Montorsi, F.; Zaurito, P.; Gandaglia, G.

ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer

2026-01-01 Longoni, M.; Falkenbach, F.; Marmiroli, A.; Le, Q. C.; Nicolazzini, M.; Catanzaro, C.; Polverino, F.; Goyal, J. A.; Graefen, M.; Musi, G.; Chun, F. K. H.; Palumbo, C.; Schiavina, R.; Longo, N.; Saad, F.; Shariat, S. F.; Quarta, L.; Moschini, M.; Gandaglia, G.; Montorsi, F.; Briganti, A.; Karakiewicz, P. I.

Re: Antonio Franco, Francesco Ditonno, Celeste Manfredi, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89:318–331

2026-01-01 Montorsi, F.; Rosiello, G.; Gandaglia, G.

Re: Nikita Sushentsev, Anne Y. Warren, Richard Colling, et al. Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.4125

2026-01-01 Bernardino, R.; Le Guevelou, J.; Autorino, R.; Gandaglia, G.; Marra, G.

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report

2025-01-01 Scorpio, G.; Francesio, A.; Piemontese, S.; Acerbis, A.; Mastaglio, S.; Giglio, F.; Bergonzi, G. M.; Lazzari, L.; Ruggeri, A.; Bruno, A.; Marktel, S.; Lupo-Stanghellini, M. T.; Assanelli, A.; Bernardi, M.; Vago, L.; Ciceri, F.; Diral, E.

Titolo	Data di pubblicazione	Autore(i)
Disease progression in myeloproliferative neoplasms: Comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression	1-gen-2020	Geyer, J. T.; Margolskee, E.; Krichevsky, S. A.; Cattaneo, D.; Boiocchi, L.; Ronchi, P.; Lunghi, F.; Scandura, J. M.; Ponzoni, M.; Hasserjian, R. P.; Gianelli, U.; Iurlo, A.; Orazi, A.
Anti-cytokine treatment for Takayasu arteritis: State of the art	1-gen-2014	Tombetti, E.; Di Chio, M. C.; Sartorelli, S.; Bozzolo, E.; Sabbadini, M. G.; Manfredi, A.; Baldissera, E.
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy	1-gen-2022	Martini, A.; Raggi, D.; Marandino, L.; Montorsi, F.; Ross, J. S.; Gibb, E. A.; Necchi, A.
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer	1-gen-2020	D'Andrea, D.; Foerster, B.; Matin, S. F.; Ku, J. H.; Muilwijk, T.; Monteiro, L. L.; Liao, R.; Petros, F. G.; Spiess, P. E.; Bivalacqua, T. J.; Hendricksen, K.; Van Rhijn, B. W. G.; Shabsigh, A.; Briganti, A.; Joniau, S.; Kassouf, W.; Pierorazio, P. M.; Margulis, V.; Necchi, A.; Shariat, S. F.
ACh receptor in ocular MG	1-gen-1994	Horton, R. M.; Conti-Tronconi, B. M.; Manfredi, A.
Do putative endogenous digitalis-like factors have a physiological role?	1-gen-1994	Hansen, O.; Doris, P. A.; Hamlyn, J. M.; Laredo, J.; Lu, Z. -R.; Hamilton, B.; Lighthall, G.; Manunta, P.
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary	1-gen-2022	Capitanio, U.; Necchi, A.; Montorsi, F.; Larcher, A.
Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply	1-gen-2026	Lanzillotta, M.; Vikse, J.; Goni, E.; Hoffmann-Vold, A. M.; Della-Torre, E.
Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease	1-gen-2025	Minici, C.; Mahajne, J.; Orfanelli, U.; Lanzillotta, M.; Della-Torre, E.
Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison	1-gen-2026	Marino, V.; Moiola, L.; Zanetta, C.; Rubin, M.; Rossi, L.; Margoni, M.; Nozzolillo, A.; Gattuso, I.; Viti, V.; Petza, E.; Rocca, M. A.; Guerrieri, S.; Filippi, M.
Silent Risk, Real-World Insight From an Italian Center: Rethinking Intracranial Aneurysm Screening in ADPKD	1-gen-2025	De Rosa, L. I.; Catania, M.; Kristiana, K.; Paolisi, M.; Bianca, P.; Farinone, S.; Manunta, P.; Vezzoli, G.; Sciarrone Alibrandi, M. T.
SunRISe-4 perioperative safety and TURBT stratification – Authors' reply	1-gen-2025	Necchi, A.; Stitou, H.; Bhanvadia, S.; Psutka, S. P.
Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review	1-gen-2026	Stabile, A.; Brancaccio, M.; Scilipoti, P.; Barletta, F. M.; Scuderi, S.; Quarta, L.; Cosenza, A.; Zaurito, P.; Porzi, M. E.; Imperiale, G.; Brembilla, G.; Cobelli, F. D.; Pini, C.; Chiti, A.; Colecchia, M.; Montorsi, F.; Gandaglia, G.; Briganti, A.
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery	1-gen-2026	Scilipoti, P.; Rosiello, G.; Salonia, A.; Briganti, A.; Necchi, A.; Moschini, M.; Montorsi, F.
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis. Reply	1-gen-2025	Mapelli, Chiara; Nassisi, Marco; Beretta, Gisella B; Miserocchi, Elisabetta; Filocamo, Giovanni; Minoia, Francesca
Re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance Imaging–led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. Eur Urol 2025;88:167–75	1-gen-2026	Montorsi, F.; Zaurito, P.; Gandaglia, G.
ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder Cancer	1-gen-2026	Longoni, M.; Falkenbach, F.; Marmiroli, A.; Le, Q. C.; Nicolazzini, M.; Catanzaro, C.; Polverino, F.; Goyal, J. A.; Graefen, M.; Musi, G.; Chun, F. K. H.; Palumbo, C.; Schiavina, R.; Longo, N.; Saad, F.; Shariat, S. F.; Quarta, L.; Moschini, M.; Gandaglia, G.; Montorsi, F.; Briganti, A.; Karakiewicz, P. I.
Re: Antonio Franco, Francesco Ditonno, Celeste Manfredi, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89:318–331	1-gen-2026	Montorsi, F.; Rosiello, G.; Gandaglia, G.
Re: Nikita Sushentsev, Anne Y. Warren, Richard Colling, et al. Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.4125	1-gen-2026	Bernardino, R.; Le Guevelou, J.; Autorino, R.; Gandaglia, G.; Marra, G.
CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report	1-gen-2025	Scorpio, G.; Francesio, A.; Piemontese, S.; Acerbis, A.; Mastaglio, S.; Giglio, F.; Bergonzi, G. M.; Lazzari, L.; Ruggeri, A.; Bruno, A.; Marktel, S.; Lupo-Stanghellini, M. T.; Assanelli, A.; Bernardi, M.; Vago, L.; Ciceri, F.; Diral, E.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 926

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext435
reserved344
open146
partially open1